別品名 |
5-ASA, Mesalamine, Asacol, Salofalk, 5-amino-2- hydroxybenzoic acid, 5-amino-2-hydroxybenzoic acid
|
別包装 |
あり
|
純度 |
>=98%
|
分子量 |
153.14
|
CAS RN® |
89-57-6
|
化合物の概要 |
Salicylic acid derivative; PPARγ agonist, potential COX-1/2 inhibitor.
|
構造 |
C7H7NO3
|
使用目的 |
5-Aminosalicylic acid exhibits anti-inflammatory, antioxidative, and anticancer activities; it is clinically used to treat inflammatory bowel disease (IBD), Crohn’s disease, and colitis, as it acts primarily in the colon. In vitro, 5-aminosalicylic acid decreases levels of ROS, increases levels of catalase and PPARγ, and stimulates PTEN signaling. In colorectal cancer cells, this compound decreases proliferation by inhibiting phospholipase D (PLD) activity and mTOR signaling.
|
その他 |
[融点]275℃-280℃ (dec) [外観]A white or almost white crystalline powder
|
参考文献 |
Poh J, Knowles S. Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs. Can J Hosp Pharm. 2014 Jan;67(1):35-8. PMID: 24634525.Managlia E, Katzman RB, Brown JB, et al. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells. Inflamm Bowel Dis. 2013 Sep;19(10):2051-60. PMID: 23867870.Baan B, Dihal AA, Hoff E, et al. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Gut. 2012 Dec;61(12):1708-15. PMID: 22187071.
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
LKT
|
A5035
|
25 G
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
常温
|
|